Skip to main content
. 2023 Mar 28;14:1116057. doi: 10.3389/fimmu.2023.1116057

Figure 3.

Figure 3

(A) Waterfall plot of the maximum reduction in target lesion diameter in 33 patients with recurrent HCC and initially diagnosed uHCC. Lesions caused by the death were not evaluable in 3 patients. (B) Histogram analysis of the proportion of the Amp11q13 and tumor response in PD-1Ab and nonPD-L1Ab groups. (C) The proportion of primary resistance in patients with Amp 11q13 among total patients, patients with the PD-1Ab and patients with nonPD-1Ab. * refer to patients with Amp11q13. (D) Kaplan-Meier estimates of PFS in Amp11q13 and nonAmp11q13 patients in PD-1Ab and Non-PD-1Ab treatment group.